Keweenaw Lnd Assn Ct (KEWL) 86.5000 $KEWL Keweenaw Land

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Keweenaw Lnd Assn Ct (KEWL) 86.5000 $KEWL

Keweenaw Land Association, Limited Announces 2016 Final Election Results
GlobeNewswire - Wed May 04, 3:00PM CDT
Keweenaw Land Association, Limited (OTC Pink:KEWL) today announced the final election results from its 2016 Annual Shareholder Meeting held May 2, 2016 in Ironwood, Michigan. Those results, as certified by Okapi Partners, confirm the re-election of both Mr. John E. Earhart and Ms. Marjorie E. Nesbitt, to three-year terms on the Keweenaw Board of Directors. Anderson, Tackman & Company were confirmed as auditors for 2016. No other proposals were brought before the shareholders for consideration. In this year's voting, over 86% of outstanding shares were represented.

Keweenaw Land Association, Limited Announces 2016 First Quarter Earnings
GlobeNewswire - Mon Apr 18, 9:00AM CDT
Keweenaw Land Association, Limited (OTC Pink:KEWL) today announced first quarter earnings for the period ending March 31, 2016. The company reported Net Income of $250,632, or $0.19 per share, compared to $142,833, or $0.11 per share, in the first quarter of 2015. EBITDA for the quarter was $492,358, up $133,854 or 37%, from $358,504 in the same period last year. Company log sales were $3,213,130 for the quarter, up $172,896, or 6%, from the $3,040,234 reported in the comparable period in 2015.

Keweenaw Land Association, Limited Announces 2015 Fourth Quarter Earnings
GlobeNewswire - Tue Jan 26, 11:03AM CST
Keweenaw Land Association, Limited (OTC Pink:KEWL) today announced fourth quarter earnings for the period ending December 31, 2015. The company reported net income of $320,523, or $0.25 per share, compared to $438,669, or $0.34 per share, in the fourth quarter of 2014. For 2015, Keweenaw recognized year-to-date net income of $1,155,839, or $0.89 per share, versus $855,860 year-to-date in 2014, or $0.66 a share, an increase of 35%. Keweenaw also reported timber sales of $3,088,864 for the quarter, up $81,669, or 3%, from the $3,007,195 that the company reported in the comparable period in 2014. Timber sales for the year were $11,283,793, versus $9,881,889 in 2014, up 14%.

Keweenaw Land Association, Limited Announces 2015 Third Quarter Earnings
GlobeNewswire - Tue Oct 20, 9:00AM CDT
Keweenaw Land Association, Limited (KEWL:OTC Pink) today announced third quarter earnings for the period ending September 30, 2015. The company reported Net Income of $571,046, or $0.44 per share, compared to $427,402, or $0.33 per share, in the third quarter of 2014. Keweenaw also reported timber sales of $3,607,626 for the quarter, up $481,961, or 15%, from the $3,125,665 that the company reported in the comparable period in 2014.

Keweenaw Land Association, Limited Announces the Appointment of James A. Mai to the Board of Directors
BusinessWire - Fri Sep 11, 3:00PM CDT
Keweenaw Land Association, Limited (KEWL: OTC Pink) today announced that the Board of Directors has authorized an expansion of the Board of Directors from six members to seven, effective immediately, and the appointment of James A. Mai, Chief Investment Officer of Cornwall Capital, to the Company's Board of Directors for a term ending in 2018. Cornwall Capital is the largest single shareholder in Keweenaw with approximately 26% of the outstanding shares.

Keweenaw Land Association, Limited Announces 2015 Second Quarter Earnings
BusinessWire - Mon Jul 20, 9:00AM CDT
Keweenaw Land Association, Limited (KEWL: OTC Pink) today announced second quarter earnings for the period ending June 30, 2015. The company reported Net Income of $121,437, or $0.09 per share, versus a Net Loss of $142,174, or $0.11 per share, in the second quarter of 2014. Keweenaw also reported timber sales of $1,547,069 for quarter, up $511,846, or 49%, from the $1,035,223 that the company reported in the comparable period in 2014.

Keweenaw Land Association, Limited Releases Investor Presentation
BusinessWire - Fri Nov 21, 10:00AM CST
Keweenaw Land Association, Limited (OTC Pink: KEWL) today released an Investor Presentation which contains information about Keweenaw's performance and strategic plan. A link to the presentation can be found by clicking here, or going to www.keweenaw.com and searching under the News link.

Brian D. Glodowski Named CEO for Keweenaw Land Association, Limited
BusinessWire - Tue Nov 18, 9:00AM CST
Keweenaw Land Association, Limited (Pink Sheets: KEWL) is pleased to announce that the Board of Directors has elected Brian Glodowski, President of the Company, to the additional position of Chief Executive Officer, succeeding David Ayer who will continue as the non-executive Chairman of the Board. Mr. Glodowski has been with Keweenaw for over 20 years and has served as President of the Company since 2012. He previously oversaw the development and implementation of the log sales and marketing program until 2005, and then assumed responsibilities for the timber and land acquisition efforts prior to his promotion as Manager of Operations in 2011. Mr. Glodowski is an active member of the timberland industry, having been recently appointed to the Executive Committee of the Michigan Forest Products Council and will be serving on the Board of Directors for the National Association of Forestland Owners, based in Washington DC, beginning in 2015. Mr. Glodowski also serves on the Board of Directors for the Ironwood Industrial Development Corporation.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading